Attached: 1 image
🏭 The EU excels in innovative medicines but faces challenges: over 50% of medicine shortages are due to manufacturing issues and we also need to be vigilant about keeping generic drug production in Europe.
Our Critical Medicine Act aims to:
💊 ensure that essential medicines are always available to EU patients, filling gaps where the market falls short
🇪🇺 boost local production
🧪 improve security of supply of key ingredients
= more stability for the EU's pharmaceutical industry.
It’s scary knowing that most of our medicine is produced in China or India. Once we get into a conflict with China they could easily cut us from from lifesaving medicine, antibiotics, etc.
looking to it, still doesn’t seem that most comes from asia. Still more APIs in europe as stated in the data, not much more for sure but more. The fact that they have more manufacturers doesn’t tell much other than it’s easier to pop up manufacturers there.
The part about production share of a single API is something much more interesting and I bet we could find better data for most valuable APIs in EU somewhere in the european union papers about collapse.
P.S. obviously the best first thing to do would be reducing the need for drugs, like reducing meat consumption and bad animal conditions and then cleaning up the air reducing cars and keeping the numbers of renewables growing
It’s scary knowing that most of our medicine is produced in China or India. Once we get into a conflict with China they could easily cut us from from lifesaving medicine, antibiotics, etc.
Novo Nordisk is based in Denmark. 40% of their sales are from the US, so I guess they could pivot to European sales.
Isn’t NN in the hormone business? Surely it helps, but it’s Rather the staple of medicine that I’m worried about.
I don’t think they are? At least here in Italy the pharmaceutical industry is very big
Check out these slides: https://progenerika.de/app/uploads/2020/11/API-Study_long-version_EN.pdf
While Italy is indeed the largest supplier in Europe, the majority comes from Asia.
thank you for the data, really appreciated
looking to it, still doesn’t seem that most comes from asia. Still more APIs in europe as stated in the data, not much more for sure but more. The fact that they have more manufacturers doesn’t tell much other than it’s easier to pop up manufacturers there.
The part about production share of a single API is something much more interesting and I bet we could find better data for most valuable APIs in EU somewhere in the european union papers about collapse.
P.S. obviously the best first thing to do would be reducing the need for drugs, like reducing meat consumption and bad animal conditions and then cleaning up the air reducing cars and keeping the numbers of renewables growing